Event

Faisal A. Fakih

MD
Florida Pulmonary Consultants & Sleep Disorder Cen

J Fredrick Pritchard

Ph.D
Celerion, Inc

Caroline Engel

BSc
Celerion, Inc.

Gerard J. Criner

MD
Lewis Katz School of Medicine at Temple University;Lewis Katz School of Medicine at Temple University, Temple University Hospital;Temple Univ Hosp;Temple Univ Hospital;Temple University;Temple Univers

Ji Seok Yoo

MSc
Yungjin Pharm. CO., LTD.

Mark T. Dransfield

MD
Lung Health Center, University of Alabama at Birmingham;UAB;Univ of Alabama Birmingham;Univ of Alabama Birmingham & Birmingham VA Med Ctr;Univ of Alabama Birmingham & Birmingham VA Med Ctr;Un

Soo-Hyun Lew

MD
Yungjin Pharm. CO., LTD.

Florence F Vickers

Ph.D
Celerion, Inc.

Yongnam Lee

Ph.D
Yungjin Pharm. CO., LTD.

Joelle Batonga

MSc
Celerion, Inc.

Thomas J. Rogers

PhD
Temple Univ Sch of Med;Temple University Sch of Med

Samir Arora

MD
Aventiv Research;Aventiv Research Inc.

A Randomized, Double-Blind, Placebo Controlled, Multicenter Phase 2a Study to Assess Safety, Daily Respiratory Symptoms, Pharmacokinetics, and Biomarker Variations After Administration of Either YPL-001, or Placebo in Patients with Moderate to .